Intellikine, Inc.
10931 N. Torrey Pines Road
Suite 103
San Diego
California
92037
United States
Tel: 858-768-6500
Website: http://www.intellikine.com/
15 articles about Intellikine, Inc.
-
Takeda Pharmaceutical Co. Ltd. to Acquire Privately-held Intellikine, Inc. for Up to $310 Million Cash
12/21/2011
-
Intellikine, Inc. Earns $4 Million in Milestone Payments for Initiation of Two Phase 1 Clinical Trials for IPI-145, a Potent Inhibitor of PI3Kdelta and PI3Kgamma
10/31/2011
-
Intellikine, Inc. Initiates Phase I Study of Targeted Cancer Therapeutic INK1117
10/12/2011
-
Intellikine, Inc., a Leading Developer of Small Molecule Drugs Targeting the PI3K/mTOR Pathway, Names Dr. Gregory Berk Chief Medical Officer
7/12/2011
-
Intellikine, Inc. and the PKD Foundation Collaborate to Advance Next-Generation Therapies for Polycystic Kidney Disease
2/10/2011
-
Intellikine, Inc. and the Multiple Myeloma Research Consortium Initiate Phase I Trial of Targeted Drug INK128
11/30/2010
-
Numerate and Intellikine, Inc. Conclude Research Collaboration to Discover Selective Inhibitors Against PI3 Kinase Alpha
8/11/2010
-
Infinity Pharmaceuticals Inc. and Intellikine, Inc. Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma; Intellikine To Receive $13.5 Million Initially In Deal Valued Up to $488 Million
7/8/2010
-
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma
3/29/2010
-
Intellikine, Inc. Appoints William Rohn to its Board of Directors
2/23/2010
-
Intellikine, Inc.: 3D Structure of Key Drug Target Sheds Light on How to Design Better Drugs
1/12/2010
-
Intellikine, Inc. Initiates Phase I Clinical Trial for Targeted Anticancer Drug INK128
1/5/2010
-
Anadys Pharmaceuticals, Inc. Moves Hepatitis C Drug Ahead on its Own, Intellikine, Inc. (JOBS) Casts a Broad Net, Sequel Pharmaceuticals Raising $8.4 Million
8/20/2009
-
Intellikine, Inc. (JOBS), Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets
8/18/2009
-
Intellikine, Inc. Completes $51 Million Financing
7/8/2009